South Korea Makes Ring-Based Blood Pressure Monitoring Official Medical Practice
A smart ring joins hypertension guidelines for the first time globally, enabling silent overnight BP tracking that could catch deadly hidden spikes.
Summary
South Korea has become the first country to officially include a cuffless, ring-type blood pressure monitor in national hypertension treatment guidelines. The device, CART BP pro by Sky Labs, uses optical sensors and AI to track blood pressure continuously, day and night, without the discomfort of traditional arm cuffs. This matters because up to 23% of people may have dangerous blood pressure spikes during sleep that routine clinic visits completely miss. Masked hypertension and morning surges are linked to strokes and heart disease, yet most people remain unaware. Wearable continuous monitoring offers a practical, low-friction way to detect these hidden patterns early, making it especially relevant for anyone serious about cardiovascular health and longevity.
Detailed Summary
Continuous blood pressure monitoring has taken a significant step forward as South Korea officially incorporates a ring-type cuffless device into its 2026 hypertension management guidelines. This is the first time any country has endorsed a ring-based blood pressure monitor at the clinical guideline level, marking a meaningful shift in how hypertension is tracked and managed.
Traditional blood pressure measurement captures a single moment in time, typically during a clinic visit, which can miss dangerous fluctuations occurring throughout the day or night. The CART BP pro ring by Sky Labs uses optical light sensors on the finger combined with AI analysis to estimate blood pressure continuously, providing a far richer picture of cardiovascular behavior than occasional snapshots allow.
The clinical urgency is substantial. Research cited in the Korean guidelines estimates that 18 to 23 percent of the general population may experience nocturnal hypertension, elevated blood pressure during sleep that standard daytime checks would never detect. Morning blood pressure surges after waking are also increasingly associated with elevated stroke and cardiac event risk, particularly in older adults. These are precisely the hidden patterns wearable monitoring is built to catch early.
From a longevity perspective, the shift toward continuous, passive health tracking represents a meaningful upgrade in preventive medicine. The easier a monitoring tool is to live with, the more consistently people use it, and consistency over time is what generates clinically useful data. Unlike traditional 24-hour ambulatory monitors that inflate repeatedly during sleep and daily activities, a ring worn passively removes almost all friction from the monitoring process.
Caveats remain. The article is a news report based on a company announcement rather than a peer-reviewed clinical trial, and independent validation of the ring's accuracy against gold-standard methods is not detailed here. Adoption in other countries will depend on regulatory approval and guideline updates elsewhere. Still, this development signals where preventive cardiovascular medicine is heading.
Key Findings
- South Korea is the first country to include a cuffless ring BP monitor in official hypertension guidelines.
- 18–23% of people may have nocturnal hypertension that routine clinic visits cannot detect.
- Morning blood pressure surges are linked to higher stroke and cardiac event risk, especially in older adults.
- Optical sensor rings track blood pressure passively all night without disrupting sleep.
- Low-friction wearable monitoring improves long-term compliance, generating more clinically useful data.
Methodology
This is a news report from Longevity.Technology summarizing a company announcement by Sky Labs and referencing the 2026 Korean Society of Hypertension Guidelines. It is not a peer-reviewed study. Evidence basis includes cited guideline statistics on nocturnal hypertension prevalence but lacks independent clinical trial data on device accuracy.
Study Limitations
The article is based on a corporate announcement and does not provide peer-reviewed accuracy data for the CART BP pro device. Independent validation against gold-standard ambulatory monitors is not discussed. Readers should consult primary guideline documents and clinical literature before drawing conclusions about device reliability or clinical equivalence.
Enjoyed this summary?
Get the latest longevity research delivered to your inbox every week.